Modeling Phenotypic Metabolic Adaptations of Mycobacterium tuberculosis H37Rv under Hypoxia

PLoS Computational Biology

Volumn 8, Issue 9, 2012, Pages

  Fang, Xin ^a   Wallqvist, Anders ^a   Reifman, Jaques ^a  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METABOLISM; METABOLITES; OXYGEN; TUBES (COMPONENTS);

CAUSATIVE AGENTS; CELL WALLS; CONDITION; DIFFERENTIAL GENE EXPRESSIONS; GENE EXPRESSION DATA; GENES EXPRESSION; M. TUBERCULOSIS; METABOLIC ADAPTATION; METABOLIC STATE; MYCOBACTERIUM TUBERCULOSIS;

GENE EXPRESSION;

ADENOSINE TRIPHOSPHATE; OXYGEN; TRIACYLGLYCEROL; TRICARBOXYLIC ACID;

ADAPTATION; ANAEROBIC METABOLISM; ARTICLE; BACTERIAL GENE; BACTERIAL METABOLISM; BIOACCUMULATION; BIOMASS; CATALYSIS; CELL GROWTH; CELL HYPOXIA; CELL WALL; COMPUTER MODEL; CONTROLLED STUDY; DOSR GENE; GENE DELETION; GENE EXPRESSION; LIFE CYCLE; METABOLIC STRESS; METABOLITE; MICROARRAY ANALYSIS; MICROBIAL ACTIVITY; MOLECULAR MODEL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYGEN CONSUMPTION; PHENOTYPE; PREDICTION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84866925914     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002688     Document Type: Article

References (73)

1. World Health Organization (2011) Global tuberculosis control 2011. Geneva: World Health Organization.
2. Campion S, Cohen MS, McMichael AJ, Galvin S, Goonetilleke N, (2011) Improved detection of latent Mycobacterium tuberculosis infection in HIV-1 seropositive individuals using cultured cellular assays. Eur J Immunol 41: 255-257.
3. LoBue PA, Enarson DA, Thoen TC, (2010) Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int J Tuberc Lung Dis 14: 1226-1232.
4. Horsburgh CR Jr, Rubin EJ, (2011) Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 364: 1441-1448.
5. Kwan CK, Ernst JD, (2011) HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 24: 351-376.
6. Gomez JE, McKinney JD, (2004) M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 84: 29-44.
7. Zhang Y, (2004) Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci 9: 1136-1156.
8. Hasan S, Daugelat S, Rao PS, Schreiber M, (2006) Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. PLOS Comput Biol 2: e61.
9. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
10. Lee SW, Jang YS, Park CM, Kang HY, Koh WJ, et al. (2010) The role of chest CT scanning in TB outbreak investigation. Chest 137: 1057-1064.
11. Barry CE 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7: 845-855.
12. Jassal MS, Aldrovandi GM, (2011) 2050: Ending the odyssey of the great white plague. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. Pharmacol Res 64: 176-179.
13. Koul A, Arnoult E, Lounis N, Guillemont J, Andries K, (2011) The challenge of new drug discovery for tuberculosis. Nature 469: 483-490.
14. Yang CM, Hsu CH, Lee CM, Wang FC, (2003) Intense uptake of [F-18]-fluoro-2 deoxy-D-glucose in active pulmonary tuberculosis. Ann Nucl Med 17: 407-410.
15. Villela AD, Sanchez-Quitian ZA, Ducati RG, Santos DS, Basso LA, (2011) Pyrimidine salvage pathway in Mycobacterium tuberculosis. Curr Med Chem 18: 1286-1298.
16. Watanabe S, Zimmermann M, Goodwin MB, Sauer U, Barry CE 3rd, et al. (2011) Fumarate reductase activity maintains an energized membrane in anaerobic mycobacterium tuberculosis. PLOS Pathog 7: e1002287.
17. Shleeva MO, Kudykina YK, Vostroknutova GN, Suzina NE, Mulyukin AL, et al. (2011) Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification. Tuberculosis 91: 146-154.
18. Parish T, Brown AC (2008) Mycobacteria protocols. New York, NY: Humana Press.
19. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, et al. (2003) Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198: 705-713.
20. Shiloh MU, Manzanillo P, Cox JS, (2008) Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3: 323-330.
21. Meena LS, Rajni, (2010) Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv. FEBS J 277: 2416-2427.
22. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, et al. (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 76: 2333-2340.
23. Wayne LG, Sohaskey CD, (2001) Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol 55: 139-163.
24. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, et al. (2001) Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc Natl Acad Sci U S A 98: 7534-7539.
25. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, et al. (2003) Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 48: 833-843.
26. Bacon J, James BW, Wernisch L, Williams A, Morley KA, et al. (2004) The influence of reduced oxygen availability on pathogenicity and gene expression in Mycobacterium tuberculosis. Tuberculosis (Edinb) 84: 205-217.
27. Muttucumaru DG, Roberts G, Hinds J, Stabler RA, Parish T, (2004) Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinb) 84: 239-246.
28. Voskuil MI, Visconti KC, Schoolnik GK, (2004) Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb) 84: 218-227.
29. Boon C, Dick T, (2002) Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol 184: 6760-6767.
30. Ideker T, Galitski T, Hood L, (2001) A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2: 343-372.
31. Kell DB, (2006) Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov Today 11: 1085-1092.
32. Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J, (2006) Cancer: a Systems Biology disease. Biosystems 83: 81-90.
33. Cho CR, Labow M, Reinhardt M, van Oostrum J, Peitsch MC, (2006) The application of systems biology to drug discovery. Curr Opin Chem Biol 10: 294-302.
34. Feist AM, Herrgard MJ, Thiele I, Reed JL, Palsson BO, (2009) Reconstruction of biochemical networks in microorganisms. Nat Rev Microbiol 7: 129-143.
35. Jamshidi N, Palsson BO, (2007) Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets. BMC Syst Biol 1: 26.
36. Beste DJ, Hooper T, Stewart G, Bonde B, Avignone-Rossa C, et al. (2007) GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism. Genome Biol 8: R89.
37. Colijn C, Brandes A, Zucker J, Lun DS, Weiner B, et al. (2009) Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production. PLOS Comput Biol 5: e1000489.
38. Fang X, Wallqvist A, Reifman J, (2009) A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis. BMC Syst Biol 3: 92.
39. Fang X, Wallqvist A, Reifman J, (2011) Modeling synergistic drug inhibition of Mycobacterium tuberculosis growth in murine macrophages. Mol Bio Syst 7: 2622-2636.
40. Bonde BK, Beste DJ, Laing E, Kierzek AM, McFadden J, (2011) Differential producibility analysis (DPA) of transcriptomic data with metabolic networks: deconstructing the metabolic response of M. tuberculosis. PLOS Comput Biol 7: e1002060.
41. Bordbar A, Lewis NE, Schellenberger J, Palsson BO, Jamshidi N, (2010) Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol Syst Biol 6: 422.
42. Fang X, Wallqvist A, Reifman J, (2010) Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosis. BMC Syst Biol 4: 160.
43. Becker SA, Palsson BO, (2008) Context-specific metabolic networks are consistent with experiments. PLOS Comput Biol 4: e1000082.
44. Shlomi T, Cabili MN, Herrgard MJ, Palsson BO, Ruppin E, (2008) Network-based prediction of human tissue-specific metabolism. Nat Biotechnol 26: 1003-1010.
45. Jensen PA, Papin JA, (2011) Functional integration of a metabolic network model and expression data without arbitrary thresholding. Bioinformatics 27: 541-547.
46. Dennis PP, Bremer H, (1974) Macromolecular composition during steady-state growth of Escherichia coli B-r. J Bacteriol 119: 270-281.
47. Albers E, Larsson C, Andlid T, Walsh MC, Gustafsson L, (2007) Effect of nutrient starvation on the cellular composition and metabolic capacity of Saccharomyces cerevisiae. Appl Environ Microbiol 73: 4839-4848.
48. Hanegraaf PP, Muller EB, (2001) The dynamics of the macromolecular composition of biomass. J Theor Biol 212: 237-251.
49. Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K, et al. (2010) The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol 192: 1662-1670.
50. Cunningham AF, Spreadbury CL, (1998) Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J Bacteriol 180: 801-808.
51. Starck J, Kallenius G, Marklund BI, Andersson DI, Akerlund T, (2004) Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. Microbiology 150: 3821-3829.
52. Boshoff HI, Barry CE 3rd, (2005) Tuberculosis- metabolism and respiration in the absence of growth. Nat Rev Microbiol 3: 70-80.
53. Daran-Lapujade P, Jansen ML, Daran JM, van Gulik W, de Winde JH, et al. (2004) Role of transcriptional regulation in controlling fluxes in central carbon metabolism of Saccharomyces cerevisiae. A chemostat culture study. J Biol Chem 279: 9125-9138.
54. Moxley JF, Jewett MC, Antoniewicz MR, Villas-Boas SG, Alper H, et al. (2009) Linking high-resolution metabolic flux phenotypes and transcriptional regulation in yeast modulated by the global regulator Gcn4p. Proc Natl Acad Sci U S A 106: 6477-6482.
55. Rustad TR, Harrell MI, Liao R, Sherman DR, (2008) The enduring hypoxic response of Mycobacterium tuberculosis. PLOS ONE 3: e1502.
56. Brennan PJ, (2003) Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 83: 91-97.
57. Morita YS, Patterson JH, Billman-Jacobe H, McConville MJ, (2004) Biosynthesis of mycobacterial phosphatidylinositol mannosides. Biochem J 378: 589-597.
58. Beste DJ, Peters J, Hooper T, Avignone-Rossa C, Bushell ME, et al. (2005) Compiling a molecular inventory for Mycobacterium bovis BCG at two growth rates: evidence for growth rate-mediated regulation of ribosome biosynthesis and lipid metabolism. J Bacteriol 187: 1677-1684.
59. Saini R, Kapoor R, Kumar R, Siddiqi TO, Kumar A, (2011) CO2 utilizing microbes- a comprehensive review. Biotechnol Adv 29: 949-960.
60. Nie L, Wu G, Culley DE, Scholten JC, Zhang W, (2007) Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications. Crit Rev Biotechnol 27: 63-75.
61. Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, et al. (2011) Global quantification of mammalian gene expression control. Nature 473: 337-342.
62. Griffin TJ, Gygi SP, Ideker T, Rist B, Eng J, et al. (2002) Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 1: 323-333.
63. de Godoy LM, Olsen JV, Cox J, Nielsen ML, Hubner NC, et al. (2008) Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455: 1251-1254.
64. Washburn MP, Koller A, Oshiro G, Ulaszek RR, Plouffe D, et al. (2003) Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 100: 3107-3112.
65. Fournier ML, Paulson A, Pavelka N, Mosley AL, Gaudenz K, et al. (2010) Delayed correlation of mRNA and protein expression in rapamycin-treated cells and a role for Ggc1 in cellular sensitivity to rapamycin. Mol Cell Proteomics 9: 271-284.
66. Lee MV, Topper SE, Hubler SL, Hose J, Wenger CD, et al. (2011) A dynamic model of proteome changes reveals new roles for transcript alteration in yeast. Mol Syst Biol 7: 514.
67. Shimizu K, (2004) Metabolic flux analysis based on 13C-labeling experiments and integration of the information with gene and protein expression patterns. Adv Biochem Eng Biotechnol 91: 1-49.
68. Newman JR, Ghaemmaghami S, Ihmels J, Breslow DK, Noble M, et al. (2006) Single-cell proteomic analysis of S. cerevisiae reveals the architecture of biological noise. Nature 441: 840-846.
69. Gmuender H, Kuratli K, Di Padova K, Gray CP, Keck W, et al. (2001) Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis. Genome Res 11: 28-42.
70. Rolfsson O, Palsson BO, Thiele I, (2011) The human metabolic reconstruction Recon 1 directs hypotheses of novel human metabolic functions. BMC Syst Biol 5: 155.
71. Mahadevan R, Schilling CH, (2003) The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. Metab Eng 5: 264-276.
72. Schellenberger J, Lewis NE, Palsson BO, (2011) Elimination of thermodynamically infeasible loops in steady-state metabolic models. Biophys J 100: 544-553.
73. Schellenberger J, Que R, Fleming RM, Thiele I, Orth JD, et al. (2011) Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat Protoc 6: 1290-1307.